The global single cell analysis market size
is expected to reach USD 5.9 billion by 2025, according to a new report by
Grand View Research, Inc. It is projected to expand at a CAGR of 17.3% during
the forecast period. High demand for early detection techniques and rapid
technological advancements are creating a significant demand for single cell
analysis. This technique is used in genomic, transcriptomic, proteomics, and
epigenetic studies.
Single cell analytics helps assess cellular
heterogeneity and aids in analysis of pathways and processes at a molecular
level. It can be performed with samples as small as a single cell. Its current
applications in diagnostics include genetic analysis, prenatal screening,
cancer genomics, and neurological therapeutics.
Rising prevalence of chronic diseases is
anticipated to drive demand for molecular assay services, subsequently leading
to the growth of this sector. Single cell analysis plays an important role in
risk management related to organ transplants, cancer, heart failure, renal
diseases, and infectious disease testing by performing fast, accurate, and
effective tests.
Full Research Report On Single Cell Analysis Market Analysis:
https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market
https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market
Further key findings from the study suggest:
·
In 2016, consumables accounted
for the largest market share owing to rapid adoption of beads and microplates,
repeat purchase of reagents, and demand for assay kits
·
Automated instruments lead the
instruments segment, owing to their advantages over manually operated variants
·
Companies in this market are
implementing strategies such as mergers and acquisitions to expand their
product portfolio and to strengthen their position. The partnership between
Illumina, Inc. and Bio-Rad Laboratories, Inc. is an example of strategies
implemented by leading players
·
Major players in this market
include, but are not limited to, Thermo Fisher Scientific, Inc.; Illumina,
Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Merck Millipore GmbH; Beckman
Coulter, Inc. (U.S.); and Becton, Dickinson and Company (U.S.).
View More Reports Of This Category By Grand View Research
At: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
global single cell analysis market on the basis of product, application, and
region:
Single Cell Analysis Product Type Outlook (Revenue, USD
Million, 2014 - 2025)
·
Consumables
o Reagents
o Assay Kits
o Other Consumables
·
Instruments
o Manual Instruments
o Microscopes
o Haemocytometers
o Automated Instruments
o Flowcytometers
o Next Generation Sequencing
o PCR Systems
o High-content Screening System
o Cell Microarrays
o Automated Cell Counters
Single Cell Analysis Application Type Outlook (Revenue,
USD Million, 2014 - 2025)
·
Cancer
·
Immunology
·
Neurology
·
Stem Cell
·
Non-invasive Prenatal Diagnosis
·
In-vitro Fertilization
Single Cell Analysis Regional Outlook (Revenue, USD
Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
·
Asia Pacific
o China
o India
·
Latin America
o Mexico
o Brazil
·
Middle East & Africa
o South Africa
Access Full Press Release of this
Report:
https://www.grandviewresearch.com/press-release/global-single-cell-analysis-market
https://www.grandviewresearch.com/press-release/global-single-cell-analysis-market
About Grand View
Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/
